Tag: Healthcare Innovations

• 

  Piramal Alternatives Invests Rs 110 Crore in Biodeal Pharmaceuticals: A Strategic Boost for Innovation and Growth

  Fueling Biodeal Pharmaceuticals' growth trajectory, Piramal Alternatives, the investment arm of the Piramal Group, has injected Rs 110 crore into the company. This strategic investment is poised to catapult Biodeal's capabilities, propelling it towards innovation, enhanced production, and expanded operations. With a focus on becoming a frontrunner in nasal spray manufacturing, Biodeal aims to leverage this infusion to fortify its infrastructure, adopt cutting-edge technology, and establish a state-of-the-art nutraceuticals facility. This collaboration signifies a significant milestone for both entities, marking a new chapter in the pharmaceutical landscape.